Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Glassia
1.2.3 Aralast NP
1.2.4 Prolastin C
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2017-2028)
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2017-2022)
2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028)
2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2017-2022)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2017-2022)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2017-2022)
5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.1.5 Grifols Recent Development
11.2 CSL
11.2.1 CSL Company Detail
11.2.2 CSL Business Overview
11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.2.5 CSL Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.3.5 Baxter Recent Development
11.4 Kamada
11.4.1 Kamada Company Detail
11.4.2 Kamada Business Overview
11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.4.5 Kamada Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.5.5 Takeda Recent Development
11.6 Abeona
11.6.1 Abeona Company Detail
11.6.2 Abeona Business Overview
11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.6.5 Abeona Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Glassia
Table 3. Key Players of Aralast NP
Table 4. Key Players of Prolastin C
Table 5. Key Players of Others
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2022)
Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2023-2028)
Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players (2017-2022)
Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2017-2022)
Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Application (2023-2028)
Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Grifols Company Detail
Table 44. Grifols Business Overview
Table 45. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 46. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 47. Grifols Recent Development
Table 48. CSL Company Detail
Table 49. CSL Business Overview
Table 50. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 51. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 52. CSL Recent Development
Table 53. Baxter Company Detail
Table 54. Baxter Business Overview
Table 55. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 56. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 57. Baxter Recent Development
Table 58. Kamada Company Detail
Table 59. Kamada Business Overview
Table 60. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 61. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 62. Kamada Recent Development
Table 63. Takeda Company Detail
Table 64. Takeda Business Overview
Table 65. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 66. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 67. Takeda Recent Development
Table 68. Abeona Company Detail
Table 69. Abeona Business Overview
Table 70. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 71. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 72. Abeona Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2021 VS 2028
Figure 2. Glassia Features
Figure 3. Aralast NP Features
Figure 4. Prolastin C Features
Figure 5. Others Features
Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2021
Figure 14. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
Figure 16. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028)
Figure 18. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028)
Figure 22. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2028)
Figure 30. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028)
Figure 38. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Country (2017-2028)
Figure 42. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 45. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 46. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 47. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 48. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 49. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Industry Market Size
